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 ABSTRACT 
 Milk fat globule membrane is a protein-lipid com-
plex that may strengthen the gut barrier. The main 
objective of this study was to assess the ability of a 
membrane-rich milk fat diet to promote the integrity of 
the gut barrier and to decrease systemic inflammation 
in lipopolysaccharide (LPS)-challenged mice. Animals 
were randomly assigned to one of 2 American Institute 
of Nutrition (AIN)-76A formulations differing only in 
fat source: control diet (corn oil) and milk fat diet (an-
hydrous milk fat with 10% milk fat globule membrane). 
Each diet contained 12% calories from fat. Mice were 
fed diets for 5 wk, then injected with vehicle or LPS (10 
mg/kg of BW) and gavaged with dextran-fluorescein 
to assess gut barrier integrity. Serum was assayed for 
fluorescence 24 h after gavage, and 16 serum cytokines 
were measured to assess the inflammatory response. 
Gut permeability was 1.8-fold higher in LPS-challenged 
mice fed the control diet compared with the milk fat 
diet. Furthermore, mice fed the milk fat diet and in-
jected with LPS had lower serum levels of IL-6, IL-10, 
IL-17, monocyte chemotactic protein (MCP)-1, inter-
feron (IFN)-γ, tumor necrosis factor (TNF)-α, and IL-3 
compared with LPS-injected mice fed the control diet. 
The results indicate that the membrane-rich milk fat 
diet decreases the inflammatory response to a systemic 
LPS challenge compared with corn oil, and the effect 
coincides with decreased gut permeability. 
 Key words:   inflammation ,  lipopolysaccharide (LPS) , 
 milk fat globule membrane (MFGM) ,  phospholipid 
 INTRODUCTION 
 Systemic inflammation causes increased intestinal 
permeability and gut barrier integrity is compromised 
leading to dysfunction (Zayat et al., 2008). Although 
the mechanisms of gut barrier dysfunction are unclear, 
it is known that pro-inflammatory cytokines, such as 
IL-6, IL-4, IL-13, IFN-γ, and tumor necrosis factor 
(TNF)-α increase the permeability of intestinal epithe-
lia (Fink, 2003; Yang et al., 2003; Lewis and McKay, 
2009; Yajima et al., 2009). 
 Several studies suggest that milk polar lipids, includ-
ing sphingomyelin and gangliosides, positively affect 
the gut by exhibiting a protective effect against colon 
cancer (Dillehay et al., 1994; Schmelz et al., 1996, 2000; 
Nilsson and Duan, 2006; Duan and Nilsson, 2009; Snow 
et al., 2010). Other studies have linked sphingolipids 
and other milk fat fractions containing phospholipids 
and gangliosides to the inhibition of a pro-inflamma-
tory response both systemically and in the gut (Park 
et al., 2005b, 2007; El Alwani et al., 2006; Dalbeth 
et al., 2010). One interesting dietary source of polar 
lipids is the milk fat globule membrane (MFGM), a 
protein-lipid complex originating from the apical sur-
face of mammary epithelial cells, which surrounds the 
fat globules in milk. During milk synthesis, triglyceride 
droplets are secreted from the endoplasmic reticulum, 
complete with a coat of polar lipids, and are thought 
to transit directly to the cell’s apical surface. As they 
are secreted from the epithelial cells into the alveolar 
lumen, they pass through the apical membrane and are 
encapsulated in the plasma membrane, complete with 
the exterior glycocalyx, resulting in discrete globules 
with 3 layers of membrane lipids (Keenan and Patton, 
1995). These milk fat globules range in diameter from 
0.1 to about 15 μm (Michalski et al., 2001, 2005; Ger-
man and Dillard, 2006) and have a nonpolar lipid core 
that is surrounded by the MFGM, containing phospho-
lipids and membrane glycoproteins (major components 
of MFGM are found in Table 1). 
 While MFGM is present in all dairy products to some 
extent, churn buttermilk, a coproduct of butter produc-
tion, is especially enriched in this membrane fraction. 
When milk fat is churned, the membrane surrounding 
the fat globules is disrupted, and the free fat is released 
as globules coalesce. The result of this process is a solid 
fat phase, butter, and an aqueous phase, churn but-
termilk, which has a long history of anecdotal health-
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promoting associations. Recently, it has been suggested 
that specific components of churn buttermilk, namely 
constituents of MFGM, may have interesting nutraceu-
tical properties (Spitsberg, 2005). As more comprehen-
sive analytical tools, such as proteomics and lipidomics, 
are used to characterize the MFGM, it is becoming clear 
that the sheer complexity of this material is impressive 
(Fauquant et al., 2005; Reinhardt and Lippolis, 2006; 
Fong et al., 2007; Cavaletto et al., 2008; Vanderghem et 
al., 2008). Furthermore, several groups have conducted 
studies to facilitate its recovery from buttermilk and 
other dairy streams (Astaire et al., 2003; Corredig et 
al., 2003; Spence et al., 2005, 2009a,b; Morin et al., 
2006a,b, 2007; Rombaut et al., 2006, 2007; Rombaut 
and Dewettinck, 2007).
Although the complexity of MFGM is well docu-
mented and methods are available to recover it from 
dairy processing operations, few studies have been 
conducted to investigate possible nutritional benefits. 
One interesting, and perhaps underappreciated, aspect 
of native milk fat globules is the size distribution and 
resulting surface area. In both humans (Rüegg and 
Blanc, 1981; Hamosh et al., 1985; Michalski et al., 2005) 
and bovines (Michalski et al., 2001, 2006), 2 distinct 
globule distributions are apparent, one with an average 
diameter of less than 1 μm and one centered around 
4 μm. As the surface area of milk fat globules in hu-
man milk has been estimated to be over 500 cm2/mL 
(Rüegg and Blanc, 1981), we hypothesized that this 
material likely has specific interactions, both physi-
cally and biochemically, with the gut epithelia during 
the digestion process. In support of this hypothesis, 
PAS 6/7 [also known as milk fat globule–EGF fac-
tor-8/lactadherin (MFG-E8)], a protein component of 
MFGM, is an important endogenous factor in main-
taining epithelial homeostasis and mucosal integrity of 
the intestinal tract. In fact, treatment of septic mice 
i.p. with recombinant MFG-E8 improved mucosal 
healing (Bu et al., 2007). Additionally, polar lipids, 
such as those found in MFGM, have been linked to 
improved resistance of epithelia to stress (Dial and 
Lichtenberger, 1984, 1987; Kivinen et al., 1995; Park 
et al., 2007; Dial et al., 2008).
In this study, the hypothesis that a milk fat-based 
diet rich in MFGM would promote gut mucosal in-
tegrity was tested in Bagg albino (BALB)/c mice 
challenged with LPS. Systemically, LPS induces an in-
flammatory response mimicking gastrointestinal injury, 
and has been used in numerous studies to emulate the 
inflammatory response seen in gram-negative bacterial 
infections (Dial et al., 2008). Because of the complex 
composition of potentially bioactive proteins and polar 
lipids of MFGM, we hypothesized that diets providing 
it as a component of the diet might protect against 
the inflammatory response and corresponding compro-
mised gut barrier integrity induced by LPS treatment. 
Furthermore, instead of using isolated components of 
MFGM, we specifically chose to use a relatively com-
plex milk fat isolate from a dairy processing operation, 
as this material is currently being produced in large 
quantities around the world and is available as a poten-
tial bioactive food ingredient.
MATERIALS AND METHODS
MFGM Isolation
Sweet cream was obtained from Cal Poly Dairy Farm 
(San Luis Obispo, CA) milk using a cream separator 
(model 345, Alfa-Laval, Richmond, VA) after pasteuri-
zation. After a tempering period of 16 h at 4°C, the 
cream was churned using a continuous pilot scale butter 
churn (Egli AG, Bütschwil, Switzerland), and butter 
fines were removed by filtration through cheese cloth.
A pilot plant-scale system (R-12 model, GEA-Niro 
Filtration, Hudson, WI) using 2 spiral polymeric 
membranes fitted in parallel on the module (10 kDa 
molecular weight cutoff, 11.33 m2 total surface area) 
was used for buttermilk concentration. The process was 
carried out at 25°C, the transmembrane pressure was 
600 kPa and the feed pump was operated at 35 Hz. The 
ultrafiltration was conducted until a 10-fold volumetric 
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Table 1. Major components of the milk fat globule membrane (MFGM)1 
Lipid
Amount  
(%)
Polar  
lipid
Amount  
(%) Protein
Triacylglycerols 62 Sphingomyelin 22 Mucin 1
Diacylglycerols 9 Phosphatidylcholine 36 Xanthine oxidoreductase
Monoacylglycerols Trace Phosphatidylethanolamine 27 PAS III
Sterols 0.2–2 Phosphatidylinositol 11 CD 36
Sterol esters 0.1–0.3 Phosphatidylserine 4 Butyrophilin
Free fatty acids 0.6–6 Lysophosphatidylcholine 2 PAS 6/7 (MFG-E8)2
Hydrocarbons 1.2     Adipophilin
Phospholipids 26–31     Fatty acid-binding protein
1Data from Keenan and Patton (1995). 
2Although not listed in the original source, MFG-E8 is another name used for PAS 6/7.
concentration factor was reached. Diafiltration (DF) 
was done adding tap water continuously at 25°C to the 
feed tank to replace the removed permeate until reach-
ing a 5-fold diafiltration factor (5 × DF). The final 
retentate was spray-dried (Niro Filterlab Spray-drier; 
GEA-Niro Filtration) to obtain buttermilk powders.
Diet Formulation
Diets were formulated to differ only in the compo-
sition of the fat. Prior to the diet formulation, the 
protein, total fat, ash, and lactose were analyzed in 
the MFGM isolate, as described previously (Morin et 
al., 2007), and the results are shown in Table 2. To 
ensure that diets were similar in micronutrients, the 
MFGM was analyzed for specific minerals by induc-
tively coupled plasma atomic emission spectroscopy 
(ICP-AES). Based on the composition of the MFGM 
powder listed in Table 2, it was determined that ad-
dition of 125 g of the isolate to 1 kg of diet would 
provide approximately 10% of the fat as phospholipids 
(6 g), as well as 68 g of casein, 17 g of whey proteins, 
approximately 20 g of triglycerides, 5g of lactose, and 
5.6 g of ash. Thus, the control diet contained 5% fat 
provided as corn oil, whereas the membrane-rich milk 
fat diet also contained 5% fat, but half of the fat was 
provided as anhydrous milk fat and half was provided 
as MFGM isolate (Tables 2 and 3). To balance the 2 
diet compositions, the casein:whey ratio in the corn oil 
diet was adjusted by substituting 17 g of whey proteins 
for casein, and the carbohydrates were adjusted by 
substituting 5 g of lactose. The MFGM isolate con-
tained significant levels of calcium, phosphorus, zinc, 
and copper, a mineral mix devoid of these components 
was used for the membrane-rich milk fat diet (Table 3), 
and specific amounts were added as listed in Table 3 to 
balance the compositions. Because of this process, the 
sucrose content of the 2 diets appears to be more dif-
ferent than it is (495 g for the control diet versus 477 g 
for the membrane-rich milk fat diet). This is due to the 
fact that the mineral mix of the control diet contains 
11.5% sucrose and, when added at 35 g/kg of diet, it 
contributes 4.1 g of sucrose. Therefore, the total sucrose 
content of the control diet was 499g/kg. The mineral 
mix of the membrane-rich milk fat diet contained 73% 
sucrose and the zinc premix contained 99.5% sucrose, 
and both of these components contributed an extra 17 
g of sucrose, resulting in 494 g/diet (Table 3). Although 
we took great care to match the nutrient profiles of the 
2 diets, a slight difference in nutrient density existed, 
with the control diet containing 3.8 kcal/g versus 3.7 
for the membrane-rich milk fat diet (Table 3). Diets 
were formulated by Dyets, Inc. (Bethlehem, PA). The 
fatty acid composition of each diet was determined us-
ing GC with flame ionization detection, as described 
previously (Snow et al., 2010).
Study Design
The hypothesis that a membrane-rich milk fat diet 
confers protective effects against LPS-induced inflam-
mation and improves gut barrier protection was tested 
using a 2 × 2 factorial design at 24- and 48-h time points. 
Weanling, male BALB/c mice were acquired from 
Charles River Labs (Wilmington, MA). Upon arrival 
to our animal facility, the mice were fed chow diets for 
2 wk to acclimatize. Subsequently, mice were randomly 
assigned to one of the following treatments for each time 
point: 1) control diet (AIN-76A), saline vehicle control 
injection (n = 6); 2) control diet, LPS injection (n = 6); 
3) membrane-rich milk fat diet, saline vehicle control 
injection (n = 6); 4) membrane-rich milk fat diet, LPS 
injection (n = 6; Figure 1). Mice were fed experimental 
diets for 5 wk. This time frame has previously been 
used in an investigation examining dietary modulation 
of LPS-induced inflammation (Peterson et al., 2008). 
On d 35, mice were injected i.p. with a dose of saline 
vehicle control or 10 mg of LPS/kg of BW (Escherichia 
coli 0111:B4; Sigma-Aldrich, St. Louis, MO). This dose 
of LPS has previously been shown to induce monocyte 
adhesion and infiltration into intestinal tissues of mice 
and induce intestinal distress (Peterson et al., 2008). To 
assess intestinal permeability, 4,000-Da Dextran-FITC 
(Sigma) suspended in PBS was gavaged immediately 
after vehicle control or LPS injection. After injection 
and gavage, animals were serially killed at 24 and 48 
h by CO2 asphyxiation. These time points were chosen 
based on data from preliminary work, wherein little 
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Table 2. Proximate composition of milk fat globule membrane 
(MFGM) isolate 
Item MFGM isolate (%)
Amount of each 
component provided by 
MFGM powder1 (g)
Protein2 68 85
 Casein   ~68
 Whey   ~17
Fat3 20 25
 Triglycerides   ~19
 Phospholipids   ~6
Ash 4.5 5.6
Lactose 4.0 5.4
Water 3.5 4.3
1These are the estimated contributions of these components to the 
diet based on the addition of 125 g of buttermilk powder to the diet 
formulation.
2The ratio of casein:whey is estimated based on the composition of 
whole milk. These values do not account for proteins of the MFGM.
3The triglyceride:phospholipid ratio of the MFGM powder was de-
termined to be 3:1, based on the analysis of these components in the 
final diet.
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plasma fluorescence was measured at 0 and 12 h after 
LPS injection, and the peak value occurred at 24 h 
(data not shown). In addition, a similar study found 
statistically significant differences in rodent membrane 
integrity using a similar design (Krimsky et al., 2000). 
All animal experimental protocols were approved by 
the Utah State University Institutional Animal Care 
and Use Committee (IACUC).
Gut Permeability and Systemic  
Inflammation Measurements
To assess gut barrier integrity, serum samples from 
all time points were assayed for dextran-FITC (Amer-
sham Typhoon Trio+ and ImageQuant TL software; 
GE Healthcare Bio-Sciences, Uppsala, Sweden). Dex-
tran-FITC permeation of the gut has shown to be a 
sensitive indicator of gut barrier integrity in vivo and 
appearance of serum FITC is positively correlated with 
intestinal insult.
Serum cytokine analysis was performed on samples 
from all time points using the Q-Plex Mouse Cytokine-
Screen (16-plex) array (Quansys Biosciences, Logan, 
UT). Cytokines analyzed include: IL-1α, IL-1β, IL-2, 
IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-17, MCP-
1, IFN-γ, TNF-α, macrophage inflammatory protein 
(MIP)-1α, granulocyte-macrophage colony-stimulating 
factor (GM-CSF), and regulated on activation, normal 
T cell expressed and secreted (RANTES). Lipopoly-
saccharide has been shown to elevate serum concen-
trations of various cytokines in mice, specifically IL-6, 
IL-10, IL-12, MCP-1, IFN-γ, and TNF-α.
Differences in diet consumption, BW, serum fluores-
cence and serum cytokine concentrations were deter-
mined by Student’s t-test. Serum cytokine data was 
normalized by log10 transformation.
Table 3. Composition of diets 
Ingredient AIN-76A1
Membrane-rich  
milk fat diet2
MFGM3 powder (g) — 125
Carbohydrate4 (g/kg of diet)
 Sucrose 495 477
 Lactose 5 —
 Corn starch 150 150
 Powdered cellulose 50 50
Protein (g/kg of diet)
 Casein 183 115
 Whey 17 —
 dl-Methionine 3 3
Fat
 Corn oil 50 —
 Anhydrous milk fat — 25
Vitamins and minerals (g/kg of diet)
 Vitamin mix5 10 10
 Mineral mix 35 17.5
 Zinc premix (5 mg/g) — 4.4
 Magnesium oxide — 0.7
 Dicalcium phosphate, anhydrous — 12.4
 Monopotassium phosphate — 2.3
 Potassium phosphate — 5.82
 Choline bitartrate 2 2
Caloric density6 (kcal/kg) 3.8 3.7
1American Institute of Nutrition diet.
2To formulate the membrane-rich milk fat diet, 125 g of buttermilk powder was added to the formulation. 
Based on the values in Table 2, this contributed approximately 68 g of casein, approximately 17 g of whey 
proteins, 5 g of lactose, 25 g of fat (19 g of triglycerides, 6 g of phospholipids), and 5.6 g of ash.
3MFGM = milk fat globule membrane.
4Less sucrose appears to be used in the formulation of the membrane-rich milk fat diet, but the difference is 
closer than it appears in the table due to the technique used to balance the mineral composition. The mineral 
mix used for the AIN-76A diet contains 11.5% sucrose (or 4.1 g/kg of diet), whereas the mineral mix used for 
the membrane-rich milk fat diet contains 73% sucrose (or 12.7 g/kg of diet) and the zinc premix contains 99.5% 
sucrose (or 4.4 g/kg of diet). The final diets contain 499 and 494 g of total sucrose for the AIN-76A and the 
membrane-rich milk fat diet, respectively.
5Due to the mineral profile of the buttermilk extract used to formulate the diet, a custom mineral mix was 
used to formulate the membrane-rich milk fat diet. To balance the minerals, several components were used, as 
listed in the table.
6Because of the many manipulations necessary to match the diets, a slight difference in caloric density existed.
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RESULTS
Weight and food intake was measured weekly. Dietary 
treatment did not significantly affect consumption or 
weight gain of animals (Figure 2).
Measurements of serum fluorescence as a function of 
time and treatment are shown in Figure 3. The results 
indicate that the membrane-rich milk fat-based diet is 
significantly protective against LPS-induced gut per-
meability. The serum fluorescence of mice fed the milk 
fat diet and injected with LPS was not different at 24 
h (5.92 ± 0.59 μg/mL) or 48 h (5.68 ± 0.55 μg/mL) 
than animals on the same diet and injected with saline 
(24 h; 5.80 ± 0.31 μg/mL and 48 h; 5.75 ± 0.46 μg/
mL). However, animals fed the control diet and injected 
with LPS had a 1.8-fold higher concentration of plasma 
fluorescence at 24 h (10.8 ± 0.18 μg/mL; P < 0.05) 
than the saline-injected animals (6.37 ± 1.29 μg/mL) 
on the same diet. Surprisingly, at 48 h, all animals fed 
the control diet and injected with LPS were dead.
At 24 h, 7 of the 16 serum cytokines assayed were 
present in significantly lower concentrations in animals 
fed the milk fat diet versus the control diet (Figure 4). 
The difference in IL-6 was the most significant (2.24 
pg of IL-6/mg of serum protein ± 0.34 vs. 4.00 pg of 
IL-6/mg of serum protein ± 0.42; P < 0.002). Other 
serum cytokines that were significantly affected were 
IL-10 (3.12 pg of IL-10/mg of serum protein ± 0.04 
vs. 3.61 pg of IL-10/mg of serum protein ± 0.30; P 
< 0.04); IL-17 (2.79 pg of IL-17/mg of serum protein 
± 0.60 vs. 3.71 pg of IL-17/mg of serum protein ± 
0.64; P < 0.03); MCP-1 (1.90 ± pg of MCP-1/mg of 
serum protein 0.67 vs. 3.07 pg of MCP-1/mg of serum 
protein ± 0.83; P < 0.05); IFN-γ (2.87 pg of IFN-γ/
mg of serum protein ± 0.29 vs. 4.13 pg of IFN-γ/mg 
of serum protein ± 0.61; P < 0.025); TNF-α (2.47 fg 
of TNF-α/mg of serum protein ± 0.12 vs. 3.21 fg of 
TNF-α/mg of serum protein ± 0.40; P < 0.03); and IL-
12p70 (3.52 pg of IL-12p70/mg of serum protein ± 0.2 
vs. 2.67 pg of IL-12p70/mg of serum protein ± 0.02). In 
addition, LPS-treated animals fed the control diet also 
had higher levels of IL-3 compared with the animals 
fed the milk fat diet, yet the latter values were below 
the detection limit and, thus, statistical determination 
of significance could not be measured. Because no mice 
fed the control diets survived at 48 h, a comparison to 
those fed the milk fat diet was not possible. However, 
it is interesting to note that of the 6 significantly af-
fected cytokines at 24 h in the milk fat-fed animals, 3 
had significantly lower concentrations at 48 h (IL-6, 
IL-17, and MCP-1), whereas 3 did not (IL-10, IFN-γ, 
and TNF-α; Figure 4). The concentrations of 9 serum 
cytokines were not significantly affected by the diets 
at 24 h: IL-1α, IL-1β, IL-2, IL-4, IL-5, MIP-1α, GM-
CSF, and RANTES. In Figure 5, the data for some of 
the cytokines not significantly affected is shown, except 
for Il-2 and Il-4, which were below the detection limit. 
Although it was not possible to compare the treatments 
at 48 h in the LPS-treated animals, it is interesting to 
note that concentrations of IL-1β, IL-5, and RANTES 
were significantly lower at 48 h than at 24 h in the milk 
fat-fed animals.
DISCUSSION
Because no significant differences were seen in feeding 
behavior and weight gain of mice between the 2 diets, 
the differences noted in gut permeability and cytokine 
induction do not appear to be linked to the amount of 
food consumed or to weight gain.
The serum fluorescence of animals fed the control 
diet and challenged with LPS was significantly higher 
than that of animals fed the milk fat diet and chal-
lenged with LPS, suggesting the membrane-rich milk fat 
diet exerted a protective effect against gastrointestinal 
leakiness (Figure 3). This is supported by the observa-
tion that the serum fluorescence levels were not dif-
ferent from animals receiving vehicle control injections 
across both diets. One unexpected result in this study 
was the death of all animals fed the control diet and 
treated with LPS at the 48-h time point. This finding 
coincides with increased gut leakiness and expression of 
the inflammatory cytokines IL-6, IL-10, IL-17, MCP-1, 
IFN-γ, TNF-α, and IL-3 in LPS-injected animals fed 
the control diets compared with membrane-rich milk 
fat diet-fed cohorts. However, it is unclear as to whether 
the observed decrease in gut permeability and circulat-
Figure 1. A 2 × 2 experimental design of treatments was used for 
each time point (24 and 48 h). Mice (n = 24) were randomly assigned 
to one of the following treatments: 1) control diet [American Institute 
of Nutrition (AIN)-76A], saline vehicle control injection (n = 6); 2) 
control diet, LPS injection (n = 6); 3) AIN-76A + milk fat diet, saline 
vehicle control injection (n = 6); or 4) AIN-76A + milk fat diet, LPS 
injection (n = 6).
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ing inflammatory cytokine levels protected the milk 
fat-fed animals from death at the 48-h time point.
Myriad reports exist of i.p. injection of LPS in mice 
to induce gastrointestinal hyperpermeability, yet meth-
odologies differ between studies and, thus, it is difficult 
to compare results directly. Many factors would be an-
ticipated to affect the results of such work including the 
mouse strain, LPS dosage, as well as the background 
diet. In addition, not all reported studies have followed 
animals to recovery, as often investigators are interested 
in characterizing molecular events in tissues available 
only in killed mice. For strains, no studies appear to 
exist that directly compare the sensitivities of differ-
ent mice to LPS. However, in chemically induced colon 
cancer models, the selection of mouse strain can result 
in large differences in tumor number (Papanikolaou et 
al., 1998; Nambiar et al., 2003), suggesting that mouse 
strain plays a role in gut physiology. Doses as low as 
0.5 and 2.0 mg/kg of i.p. administered LPS have been 
used to induce gut permeability in 129Sv/J mice (Mc-
Cafferty et al., 2002) and C57B1/6J mice (Han et al., 
2004), and thus, our use of 10 mg/kg may have been 
unnecessarily high.
The selection of the LPS dose (10 mg/kg) and the 
mouse strain (BALB/c) was based on the study of 
Peterson et al. (2008), and according to the authors, 
animals were also fed the AIN-76A diet (personal com-
munication). However, that study was terminated at 24 
h, and thus, it is not clear if those animals would have 
succumbed to the stress as our control animals did. In 
a separate study conducted on BALB/c mice, Krakauer 
et al. (2010) determined that an approximately 4 mg/
kg dose of LPS caused 48% lethality, yet did not provide 
any information on the background diet. In preliminary 
work in our laboratory using the same mouse strain 
and LPS dose, no animal deaths were observed at the 
48-h time point. However, animals were fed standard 
chow diets. A major difference in these 3 diets is the 
fat source, as the AIN-76A is made with corn oil, our 
membrane-rich milk fat diet with milk fat, and the 
chow diet with soybean oil. The fatty acid composition 
of all 3 diets is shown in Table 4 and from the data, 
it is clear that the essential fatty acid (EFA) composi-
tion is very different. The two 18-carbon EFA, linoleic 
acid (C18:2 n-6) and linolenic acid (C18:3 n-3), can be 
further elongated and desaturated to create highly un-
saturated fatty acids such as arachidonic acid (ARA; 
C20:4 n-6), eicosapentaenoic acid (EPA; C20:5 n-3), 
and docosahexaenoic acid (DHA; C22:6 n-3; Nakamura 
et al., 2004). The long-chain n-6 polyunsaturated fatty 
acid, ARA, is a precursor for inflammatory eicosanoids, 
whereas the long-chain n-3 fatty acids, EPA and DHA 
inhibit the metabolism of ARA to proinflammatory 
eicosanoids and serve as weakly inflammatory or anti-
inflammatory eicosanoids themselves (Calder, 2008). 
Therefore, the dietary ratios and concentrations of n-6 
and n-3 fatty acids can directly affect tissue levels of 
eicosanoid precursors, and subsequently, inflammatory 
processes. In support of this possibility, in a separate 
study we conducted with these 2 diets, the ARA level 
in red blood cells of Fisher-344 rats was significantly 
higher, whereas the DHA level was lower (Snow et al., 
2010).
As the diets used in this study had several notable dif-
ferences, further studies will be necessary to determine 
which component, or group of components, in the mem-
brane-rich milk fat diet were responsible for protecting 
the mice against LPS-induced gut permeability. The 
major difference in the diets was the fat composition, 
with the milk fat diet containing fewer polyunsaturated 
Figure 2. Effect of experimental diets on consumption (A) and 
total weight gain (B). Values are means (n = 36 control diet, n = 33 
milk fat diet) ± SD. Experimental diets did not significantly affect 
consumption or weight gain.
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fatty acids, a lower n6:n3 ratio, more polar lipids, and 
short-chain fatty acids. Although the diets did contain 
similar levels of total protein, the membrane-rich milk 
fat diet contained proteins originating from the MFGM. 
Of the main protein components of MFGM listed in 
Table 1, only MFG-E8 has been associated with direct 
effects in promoting epithelial barrier function, and that 
was with recombinant protein injected i.p. (Bu et al., 
2007). It is important to keep in mind that the dietary 
MFGM proteins fed in this study were subjected to 
pasteurization in the production of the material and to 
the digestive enzymes of the mice. Thus, it is unclear 
to what extent the proteins may have survived intact 
in the gut in the active form, and how this may have 
provided protection. One class of MFGM proteins, the 
mucins, are resistant to host digestive enzymes, and 
may have indirectly offered protection in our study via 
binding and neutralizing gram-negative bacteria. Previ-
ous studies have shown that mucins are resistant to 
host digestion (Ward et al., 2005) and effectively bind 
gram-negative species such as Escherichia coli (Schro-
ten et al., 1992). It is conceivable that the mucins may 
decrease the numbers of certain bacteria in the gut and 
thus, secondary exposure to gut-derived LPS in animals 
suffering from gastrointestinal hypermeability.
Several previous studies, both in vitro and in vivo, 
have demonstrated the ability of milk-derived constitu-
ents to strengthen the gut barrier. For example, with 
mammary and kidney cells in culture, Stelwagen and 
Ormrod (1998) showed that a component of whey from 
cows immunized with a multivalent bacterial vaccine 
prevented barrier leakiness induced by EGTA and en-
hanced restoration of the barrier after 24 h. According 
to the authors, the component responsible was primarily 
carbohydrate in nature. In rats subjected to heat stress, 
Prosser et al. (2004) demonstrated that supplementa-
tion with 0.4 g/d with either bovine colostrum or goat 
milk powder decreased permeability of the gut to 27 and 
10% of the control values, respectively. Although the 
factor responsible for stimulating gut barrier resistance 
to heat was not identified in the colostrum or milk pow-
ers, it was not associated with either the casein or the 
fat fraction, as both were removed in the preparation of 
powders used in a preliminary cell culture experiment. 
In a more recent study, bovine colostrum was shown to 
decrease intestinal barrier damage, bacterial translo-
cation, and the accompanying systemic inflammatory 
response induced by ischemia/reperfusion (I/R) injury 
in Sprague-Dawley rats when compared with saline and 
skim milk (Choi et al., 2009). Unlike the previous stud-
ies, the colostrum used as a treatment in their work 
was applied after the gut injury was induced via the 
I/R stress. Taken together, these data, along with the 
results of our study, indicate that certain components 
of milk may have the ability to protect the gut barrier 
against stress-induced leakiness and also may have the 
Figure 3. Effect of experimental diets and treatments on gut permeability at 24 and 48 h. The LPS-challenged mice fed milk fat diets had 
the same fluorescence levels as mice receiving saline vehicle control injection and the levels were significantly lower than those of LPS-challenged 
mice fed the control diet (*P < 0.05). Data are mean dextran-FITC concentrations (μg/mL of serum) ± SD.
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Figure 4. Significant effects of dietary treatment on serum cytokine levels after LPS challenge at 24 and 48 h. All animals fed the control 
diet and challenged with LPS died before the 48-h time point. IL-6 (A), IL-10 (B), IL-17 (C), monocyte chemotactic protein (MCP)-1 (D), IFNγ 
(E), tumor necrosis factor (TNF)-α (F), and IL-12p70 (G) all had significantly decreased serum concentrations 24 h after LPS challenge. IL-3 
(H) serum concentrations were below the detection limit after the 24- and 48-h time points. Data are log10 transformed mean cytokine concen-
trations per milligram of serum protein ± SD. The significance of the differences from the control diet (24 h) was *P < 0.05 and **P < 0.005.
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ability to decrease the systemic damage that occurs 
from a dysfunctional gut barrier. Interestingly, in new-
born infants, the gut barrier is not fully developed and 
is permeable to intact sugars and proteins (Weaver et 
al., 1984), and thus, one can hypothesize that compo-
nents of milk might specifically improve gut function.
Of all the components that were present in the 
membrane-rich milk fat diet, but not the control diet, 
Figure 5. Effects of dietary treatment on serum cytokine levels after LPS challenge at 24 and 48 h. All animals fed the control diet and chal-
lenged with LPS died before the 48-h time point. IL-1α (A), IL-1β (B), IL-5 (C), macrophage inflammatory protein (MIP)-1α (D), granulocyte-
macrophage colony-stimulating factor (GM-CSF; E), and regulated on activation, normal T cell expressed and secreted (RANTES; F) did not 
have significant changes in serum concentrations 24 h after LPS challenge. Data are log10 transformed mean cytokine concentrations per mil-
ligram of serum protein ± SD. The significance of the differences from the control diet (24 h) was **P < 0.005.
and may have provided the protection, the polar lipids 
have been the most studied. The barrier properties of 
the gut are provided, in part, by the surface mucous 
that lines the gastrointestinal tract and is rich in hy-
drophobic lipid constituents such as phospholipids. 
Intraperitoneal LPS injection has been demonstrated 
to compromise gut barrier integrity by decreasing the 
surface hydrophobicity of the gut epithelia (Dial et al., 
2002). This decrease in gut surface hydrophobicity is 
thought to be mediated through bile salts (Dial et al., 
2002) and increased activity of secretory phospholipase 
A2 (sPLA2) in the gastric and ileal lumens (Zayat et 
al., 2008). Elevated expression of sPLA2 in the gut in-
creases membrane phospholipid hydrolysis, resulting in 
the release of lysophospolipids and free fatty acids and 
ultimately results in compromised gut barrier integrity. 
Interestingly, it appears that exogenous polar lipids 
may decrease these effects. According to Dial et al. 
(2008), orally administered phosphatidylcholine (PC; 
100 mg/kg) in rats, when provided 1 h before i.p. in-
jection of LPS, significantly decreases the permeability 
of both gastric and ileal tissues, yet does not prevent 
the systemic TNF-α response or the increase in gastric 
fluid volume. The membrane-rich milk fat diet used in 
the study described here contained approximately 0.6% 
total polar lipids compared with 0.09% found in the 
control diet; however, unlike the study of Dial et al. 
(2008), in which the exogenous PC was fed acutely, the 
mice in our study received the membrane-rich diet for 
the length of the study.
2WKHU&RPSRQHQWVRI0)*0
Another polar lipid fraction of the MFGM that af-
fects barrier properties of the gut is the gangliosides. 
Park et al. (2005a) found that supplementing a rodent 
diet for 2 wk with 0.1% of a ganglioside-rich lipid iso-
late from bovine milk led to significantly more gan-
glioside in the intestinal mucosa and to a decrease in 
the cholesterol:ganglioside ratio. Using a similar experi-
mental design in rats, this group has also shown that 
dietary gangliosides significantly decrease the mucosal 
and systemic inflammatory response to LPS injected 
i.p. and protects the degradation of the tight junction 
protein, occludin (Park et al., 2007).
The results of this study indicate that the inflamma-
tory response in the animals fed the control diet was 
significantly greater than in those fed the milk fat diet. 
The decreased serum levels of several cytokines in mice 
fed the experimental diet suggest some component of 
the milk fat diet decreased the inflammatory response 
following stress. However, based on our experimental 
design and the data collected, it is unclear how the 
gut leakiness and inflammation are related. Our results 
are consistent with those investigating the effects of 
dietary polar lipids on inflammation, suggesting that 
the high polar lipid content of MFGM could be respon-
sible for the lowered systemic inflammatory response. 
For example, using both a cell culture and a mouse 
model of acute gout, Dalbeth et al. (2010) found that a 
milk fat extract, rich in phospholipids and gangliosides, 
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Table 4. Fatty acid composition (%) of diets 
Fatty acid1 AIN-76A2
Membrane-rich  
milk fat diet
Chow  
diet
C4:0 n.d.3 2.7 n.d.
C6:0 n.d. 2.5 n.d.
C8:0 n.d. 1.6 n.d.
C10:0 n.d. 3.3 n.d.
C12:0 n.d. 3.3 n.d.
C14:0 0.5 10.3 1.0
C15:0 0.1 1.0 0.1
C16:0 11.4 27.4 15.1
C16:1n7 0.2 1.6 1.7
C18:0 2.2 11.5 3.3
C18:1n7 trans 0.1 2.7 n.d.
C18:1n9 27.4 23.6 19.3
C18:2n6 56.4 4.8 42.9
C18:2n3 1.0 0.5 4.9
Calories from PUFA4 (%) 6.9 0.6 9.5
n6:n3 ratio 56.4 9.4 6.4
1Only fatty acid contributions >1.0% to at least one diet are shown.
2American Institute of Nutrition diet.
3Not detected.
4The % calories from polyunsaturated fatty acids (PUFA) was determined using the equation: %cal from PUFA 
= % PUFA × % of calories from fat.
exhibited dose-dependent effects in preventing cytokine 
secretion (cell culture) and peritonitis (mouse model). 
Interestingly, Treede et al. (2007) have shown in vitro 
in Caco-2 cells that exogenous phosphatidylcholine ex-
erts at least part of its anti-inflammatory effect by sup-
pressing activation of NF-κB by TNF-α, and inhibiting 
translocation of this transcription factor to the nucleus, 
which subsequently decreases downstream activation 
of further inflammation. In fact, when both PC and 
lyso-PC were provided to the Caco-2 cells along with 
TNF-α, the expression of several cytokines was attenu-
ated, whereas exogenous phosphatidylethanolamine 
had no effect. Therefore, the inflammatory response in 
the mice fed the membrane-rich milk fat diet may have 
been attenuated due to the effects of the dietary PC.
The results of this study indicate that replacing corn 
oil in the AIN-76A diet with a membrane-rich milk fat 
isolate significantly improves the barrier properties of 
the gut in mice subjected to LPS stress and also attenu-
ates the systemic inflammatory response. Our results 
are consistent with other studies in rodents, which have 
documented the efficacy of polar lipids in protecting the 
gut barrier against stress as well as decreasing systemic 
inflammation, and yet we cannot rule out contribution 
from other components. Although the diets used in this 
study were formulated to differ only in the fat source, 
the use of a complex material like MFGM makes it 
impossible to associate the stress protection with any 
single component. Conversely, MFGM is hypothesized 
to contain many constituents with beneficial bioactivity 
(Spitsberg, 2005) and is available as an ingredient to 
potentially modulate the barrier properties of the gut 
without the necessity of isolating specific components.
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